Daniel Springer, President and CEO of
DocuSign (DOCU), recently added 18,700 shares to his holdings. That increased his stake by 1.1 percent, and came to a total price of just over $2.4 million.
This is Springer’s third buy in the past few weeks, following a 1,076 share pickup for $152,000 on December 9, and a 33,675 pickup for $4.87 million on December 7. That’s amid the sale of shares from other company insiders and directors.
Overall, insiders own 2.2 percent of company shares.
Shares of the signatory verification technology company are now down about 47 percent over the past year, after first rallying at the start of the pandemic. Even with that drop, revenue rose 42 percent in 2021, although the company has remained unprofitable.
Action to take: The recent drop reflects shorter-term trends like the end of the pandemic rather than the company’s long-term potential, as signature verification remains a critical tool for the modern workforce. That makes shares a reasonable long-term buy here, although don’t expect to get paid to wait with a dividend.
For traders, shares appear to be attempting to rebound after a massive drop in December. A longer-dated call option trade, like the September $160 calls, could be a solid winner over the next few months. Last going for about $17.50, traders can likely nab high double-digit gains on a rebound in shares before expiration.
Disclosure: The author of this article has no position in the company mentioned here, but may trade after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.